Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Treatment and control of hypertension in the community: a prospective analysis.

Lloyd-Jones DM, Evans JC, Larson MG, Levy D.

Hypertension. 2002 Nov;40(5):640-6.

2.

Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.

Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D.

Hypertension. 2000 Oct;36(4):594-9.

3.

Hypertension in adults across the age spectrum: current outcomes and control in the community.

Lloyd-Jones DM, Evans JC, Levy D.

JAMA. 2005 Jul 27;294(4):466-72.

PMID:
16046653
4.

[Factors associated with poor blood pressure control in hypertensive black Africans: cross-sectional study of 456 hypertensive patients from Burkina Faso].

Yaméogo NV, Kagambèga LJ, Millogo RC, Kologo KJ, Yaméogo AA, Mandi GD, Ilboudo E, Toguyeni BJ, Samadoulougou AK, Zabsonré P.

Ann Cardiol Angeiol (Paris). 2013 Feb;62(1):38-42. doi: 10.1016/j.ancard.2012.05.001. Epub 2012 May 21. French.

PMID:
22677180
5.

Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.

Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, Mureddu G, Pede S, Maggioni AP, Lucci D, Reboldi G; Cardio-Sis investigators.

Lancet. 2009 Aug 15;374(9689):525-33. doi: 10.1016/S0140-6736(09)61340-4. Erratum in: Lancet. 2009 Sep 12;374(9693):880.

PMID:
19683638
6.
7.

Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension.

Fagard RH, Staessen JA, Thijs L, Bulpitt CJ, Clement D, de Leeuw PW, Jääskivi M, Mancia G, O'Brien E, Palatini P, Tuomilehto J, Webster J; Systolic Hypertension in Europe Trial Investigators.

J Hypertens. 2004 Jan;22(1):81-7.

PMID:
15106798
8.

Antihypertensive treatment is not a risk factor for major cardiovascular events in the Gubbio residential cohort study.

Lanti M, Puddu PE, Vagnarelli OT, Laurenzi M, Cirillo M, Mancini M, Zanchetti A, Menotti A.

J Hypertens. 2015 Apr;33(4):736-44; discussion 744. doi: 10.1097/HJH.0000000000000490.

PMID:
25915878
10.

Prevalence of hypertension and rate of blood pressure control as assessed by home blood pressure measurements in a rural Japanese community, Ohasama.

Nagai K, Imai Y, Tsuji I, Ohkubo T, Sakuma M, Watanabe N, Kato J, Kikuchi N, Nishiyama A, Sekino M, Itoh O, Satoh H, Hisamichi S, Abe K.

Clin Exp Hypertens. 1996 Jul;18(5):713-28.

PMID:
8781755
11.

Baseline depressive symptoms are not associated with clinically important levels of incident hypertension during two years of follow-up: the multi-ethnic study of atherosclerosis.

Delaney JA, Oddson BE, Kramer H, Shea S, Psaty BM, McClelland RL.

Hypertension. 2010 Feb;55(2):408-14. doi: 10.1161/HYPERTENSIONAHA.109.139824. Epub 2010 Jan 11.

12.

[Prevalence of isolated diastolic hypertension and associated cardiovascular risk: four years follow up results].

Dong Y, Yao T, Sun J, Song S, Zhou J, Gao X, Chen S, Cai J, Wu S.

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Jun;42(6):520-5. Chinese.

PMID:
25164229
13.

Isolated systolic hypertension: pathophysiology, consequences and therapeutic benefits.

Kocemba J, Kawecka-Jaszcz K, Gryglewska B, Grodzicki T.

J Hum Hypertens. 1998 Sep;12(9):621-6. Review.

PMID:
9783491
14.

Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative.

Wassertheil-Smoller S, Anderson G, Psaty BM, Black HR, Manson J, Wong N, Francis J, Grimm R, Kotchen T, Langer R, Lasser N.

Hypertension. 2000 Nov;36(5):780-9.

15.

Hypertension management and lifestyle changes following screening for hypertension in an Asian low socioeconomic status community: a prospective study.

Wee LE, Wong J, Chin RT, Lin ZY, Goh DE, Vijakumar K, Vong KY, Tay WL, Lim HT, Koh GC.

Ann Acad Med Singapore. 2013 Sep;42(9):451-65.

16.

Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.

Mosterd A, D'Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, Levy D.

N Engl J Med. 1999 Apr 22;340(16):1221-7.

17.
18.

Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study.

Haider AW, Larson MG, Franklin SS, Levy D; Framingham Heart Study.

Ann Intern Med. 2003 Jan 7;138(1):10-6.

PMID:
12513039
19.

Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.

Mallion JM, Genès N, Vaur L, Clerson P, Vaïsse B, Bobrie G, Chatellier G.

J Hum Hypertens. 2001 Dec;15(12):841-8.

20.

Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.

Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW.

BMC Fam Pract. 2013 Jun 24;14:88. doi: 10.1186/1471-2296-14-88.

Supplemental Content

Support Center